Pharmaceutical

M&A in pharmaceutical in Australia remained flat in Q2 2023

In Australia pharmaceutical industry, there were 8 M&A deals announced in Q2 2023, worth a total value of $497.6m, according to GlobalData's Deals Database.

Jul 27, 2023 - 20:00
In Australia pharmaceutical industry, there were 8 M&A deals announced in Q2 2023, worth a total value of $497.6m, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

M&A in pharmaceutical in Brazil decreased in Q2 2023

Next Article

How artificial intelligence M&A performed in the pharmaceutical industry in Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

(CST-2032 + nadolol) by CuraSen Therapeutics for Dement...

Oct 29, 2023

STAT+: FDA approves Sage Therapeutics’ rapid-acting medication for postpartum depression but not major depression

STAT+: FDA approves Sage Therapeutics’ rapid-acting med...

Aug 5, 2023

Innate Pharma and Takeda sign licence deal to develop ADCs for coeliac disease

Innate Pharma and Takeda sign licence deal to develop A...

Apr 3, 2023